SNAI2 and ovarian carcinoma: To study the clinical implications of FILIP1L in regulating the WNT/β-catenin pathway and chemoresistance, we examined the expression of FILIP1L, β-catenin, SNAIL and SLUG in ovarian cancer specimens from patients in whom clinical outcome data were available.